<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27240146</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN><JournalIssue CitedMedium="Internet"><Volume>496</Volume><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Virology</Title><ISOAbbreviation>Virology</ISOAbbreviation></Journal><ArticleTitle>ATP1B3: a virus-induced host factor against EV71 replication by up-regulating the production of type-I interferons.</ArticleTitle><Pagination><StartPage>28</StartPage><EndPage>34</EndPage><MedlinePgn>28-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2016.05.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0042-6822(16)30122-2</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) infection can cause severe diseases, and is becoming increasingly common in children. In the current study, we carried out yeast two-hybrid assays to screen human proteins that could interact with 3A protein of EV71. Human &#x3b2;3 subunit of Na(+)/K(+)-ATPase (ATP1B3) protein was demonstrated to interact with the 3A protein of EV71. Although 3A protein had no effect on the expression of ATP1B3, EV71 infection resulted in elevated expression of ATP1B3 in RD cell line, both on messenger RNA (mRNA) and protein levels. Interestingly, knockdown of ATP1B3 could significantly increase the replication of EV71, whereas overexpression of ATP1B3 significantly suppressed the replication of EV71 in RD cells. Furthermore, we demonstrated that the expression of ATP1B3 could induce the production of type-I interferons. Our study demonstrated that ATP1B3 inhibit EV71 replication by enhancing the production of type-I interferons, which could act as a potential therapeutic target in EV71 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yanfang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cancer Biology Research Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Weiyong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: wyliu@hust.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ziyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: zysun@tjh.tjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Virology</MedlineTA><NlmUniqueID>0110674</NlmUniqueID><ISSNLinking>0042-6822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C500427">3A protein, coxsackievirus B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C519304">ATP1B3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 7.2.2.13</RegistryNumber><NameOfSubstance UI="D000254">Sodium-Potassium-Exchanging ATPase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000254" MajorTopicYN="N">Sodium-Potassium-Exchanging ATPase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3A protein</Keyword><Keyword MajorTopicYN="N">ATP1B3</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">Type I IFNs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27240146</ArticleId><ArticleId IdType="pmc">PMC7127048</ArticleId><ArticleId IdType="doi">10.1016/j.virol.2016.05.013</ArticleId><ArticleId IdType="pii">S0042-6822(16)30122-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arita M., Takebe Y., Wakita T., Shimizu H. A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection. J. Gen. Virol. 2010;91:2734&#x2013;2744.</Citation><ArticleIdList><ArticleId IdType="pubmed">20660150</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov G.A., van Kuppeveld F.J. (+)RNA viruses rewire cellular pathways to build replication organelles. Curr. Opin. Virol. 2012;2:740&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102821</ArticleId><ArticleId IdType="pubmed">23036609</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov G.A., Fogg M.H., Ehrenfeld E. Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J. Virol. 2005;79:7207&#x2013;7216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1112117</ArticleId><ArticleId IdType="pubmed">15890959</ArticleId></ArticleIdList></Reference><Reference><Citation>Besirli C.G., Gong T.W., Lomax M.I. The Atp1b3 gene for Na,K-ATPase beta 3 subunit maps to mouse chromosome 9, and a related gene, Atp1b3-rs, maps to mouse chromosome 3. Mamm. Genome: Off. J. Int. Mamm. Genome Soc. 1998;9:171&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">9457684</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkard C., Verheije M.H., Haagmans B.L., van Kuppeveld F.J., Rottier P.J.M., Bosch B.J., de Haan C.A.M. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells. J. Virol. 2015;89:4434&#x2013;4448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4442369</ArticleId><ArticleId IdType="pubmed">25653449</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., Jegathesan M., Anderson L.J. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the outbreak study group. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 2000;31:678&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiampanichayakul S., Szekeres A., Khunkaewla P., Moonsom S., Leksa V., Drbal K., Zlabinger G.J., Hofer-Warbinek R., Stockinger H., Kasinrerk W. Engagement of Na,K-ATPase beta3 subunit by a specific mAb suppresses T and B lymphocyte activation. Int. Immunol. 2002;14:1407&#x2013;1414.</Citation><ArticleIdList><ArticleId IdType="pubmed">12456588</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe S.S., Kirkegaard K. Intracellular topology and epitope shielding of poliovirus 3A protein. J. Virol. 2004;78:5973&#x2013;5982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC415829</ArticleId><ArticleId IdType="pubmed">15140995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chruewkamlow N., Pata S., Mahasongkram K., Laopajon W., Kasinrerk W., Chiampanichayakul S. Beta3 subunit of Na,K ATPase regulates T cell activation with no involvement of Na,K ATPase activity. Immunobiology. 2015;220:634&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">25678464</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X., Sun Z.R., Ren G.W., Wang G.L., Qi Y., Ma Y.P., Ruan Q. Interaction between human cytomegalovirus UL136 protein and ATP1B1 protein. Braz. J. Med. Biol. Res. 2011;44:1251&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pubmed">22030864</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C.L., Yeo H., Ye H.Q., Liu S.Q., Shang B.D., Gong P., Alonso S., Shi P.Y., Zhang B. Inhibition of enterovirus 71 by adenosine analog NITD008. J. Virol. 2014;88:11915&#x2013;11923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178731</ArticleId><ArticleId IdType="pubmed">25100827</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorobantu C.M., Ford-Siltz L.A., Sittig S.P., Lanke K.H., Belov G.A., van Kuppeveld F.J., van der Schaar H.M. GBF1- and ACBD3-independent recruitment of PI4KIIIbeta to replication sites by rhinovirus 3A proteins. J. Virol. 2015;89:1913&#x2013;1918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300732</ArticleId><ArticleId IdType="pubmed">25410869</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T., Chikahira M., Yoshida S., Ebira H., Hasegawa A., Totsuka A., Nishio O. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol. Immunol. 2002;46:621&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">12437029</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q.Q., Yuan S.L., Zhang C., Wang Y., Wang Y.Z., He G.M., Zhang S.Y., Altmeyer R., Zou G. Discovery of Itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A. Antimicrob. Agents Chemothr. 2015;59:2654&#x2013;2665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394834</ArticleId><ArticleId IdType="pubmed">25691649</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A.L. Picornavirus&#x2013;host interactions to construct viral secretory membranes. Prog. Mol. Biol. Transl. Sci. 2015;129:189&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">25595805</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu N.Y., Ilnytska O., Belov G., Santiana M., Chen Y.H., Takvorian P.M., Pau C., van der Schaar H., Kaushik-Basu N., Balla T., Cameron C.E., Ehrenfeld E., van Kuppeveld F.J., Altan-Bonnet N. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010;141:799&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.C., Wang H.C., Shih S.R., Teng I.F., Tseng C.P., Hsu J.T. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J. Infect. Dis. 2011;203:1784&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R.L., Kao L.T., Lin S.J., Wang R.Y., Shih S.R. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One. 2013;8:e63431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.S., Lin T.Y., Chiang P.S., Li W.C., Luo S.T., Tsao K.C., Liou G.Y., Huang M.L., Hsia S.H., Huang Y.C., Chang S.C. An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr. Infect. Dis. J. 2010;29:1030&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">20543760</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Wang Y., Li X., Li X., Cao H., Zheng S.J. Critical roles of glucocorticoid-induced leucine zipper in infectious bursal disease virus (IBDV)-induced suppression of type I Interferon expression and enhancement of IBDV growth in host cells via interaction with VP4. J. Virol. 2013;87:1221&#x2013;1231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554076</ArticleId><ArticleId IdType="pubmed">23152515</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.L., Lee Y.P., Wang Y.F., Lei H.Y., Liu C.C., Wang S.M., Su I.J., Wang J.R., Yeh T.M., Chen S.H., Yu C.K. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86:3263&#x2013;3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Hao Q., Peng N., Yue X., Wang Y., Chen Y., Wu J., Zhu Y. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon. Hepatology. 2012;56:57&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">22318991</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Wu S., Xiong Y., Li T., Wen Z., Yan M., Qin K., Liu Y., Wu J. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One. 2014;9:e96051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4002479</ArticleId><ArticleId IdType="pubmed">24776922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M.C., Kung H.F., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012;86:3767&#x2013;3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik N., Canfield V., Sanchez-Watts G., Watts A.G., Scherer S., Beatty B.G., Gros P., Levenson R. Structural organization and chromosomal localization of the human Na,K-ATPase beta 3 subunit gene and pseudogene. Mamm. Genome: Off. J. Int. Mamm. Genome Soc. 1998;9:136&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">9457675</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am. 2001;32:236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Melian E.B., Plosker G.L. Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C. Drugs. 2001;61:1661&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pubmed">11577799</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi S., Li Y., Yan J., Gao G.F. Na(+)/K (+)-ATPase beta1 subunit interacts with M2 proteins of influenza A and B viruses and affects the virus replication. Sci. China Life Sci. 2010;53:1098&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">21104370</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health and Family Planning Commision of People's Republic of China, 2016.&#x3008;http://www.nhfpc.gov.cn/zhuzhan/yqxx/lists.shtml&#x3009;</Citation></Reference><Reference><Citation>Nishitsuji H., Sugiyama R., Abe M., Takaku H. ATP1B3 Modulates the restriction of HIV-1 production and of NF-kappaB activation by BST-2. J. Biol. Chem. 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4813497</ArticleId><ArticleId IdType="pubmed">26694617</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008;89:1&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18089727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghipour S., Bek E.J., McMinn P.C. Selection and characterisation of guanidine-resistant mutants of human enterovirus 71. Virus Res. 2012;169:72&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">22814431</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuda G.M., Chang W.K., Yeung C.Y., Tang P.S. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr. Infect. Dis. J. 1987;6:206&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">3562141</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001;14:778&#x2013;809. Table of contents.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89003</ArticleId><ArticleId IdType="pubmed">11585785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato C., Syoji M., Ueki Y., Sato Y., Okimura Y., Saito N., Kikuchi N., Yagi T., Numakura H. Isolation of enterovirus 71 from patients with hand, foot and mouth disease in a local epidemic on March 2006, in Miyagi prefecture, Japan. Jpn. J. Infect. Dis. 2006;59:348.</Citation><ArticleIdList><ArticleId IdType="pubmed">17060708</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W.F., Hou X.L., Peng H.J., Zhang L., Li Y.Y., Gu Z.W., Jiang Q.B., Shi M., Ji Y., Jiang J.T. MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells. Virol. J. 2014:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4304142</ArticleId><ArticleId IdType="pubmed">25548009</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Chow V.T., Phoon M.C., Chan K.P., Poh C.L. Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV71-specific primers. J. Clin. Microbiol. 2002;40:2823&#x2013;2827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC120643</ArticleId><ArticleId IdType="pubmed">12149336</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifter S.A., Bhattacharyya N., Pillay R., Florido M., Triccas J.A., Britton W.J., Feng C.G. Functional interplay between type I and II interferons is essential to limit influenza A virus-induced tissue inflammation. PLoS Pathog. 2016;12:e1005378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4701664</ArticleId><ArticleId IdType="pubmed">26731100</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoule F., Brisac C., Pelletier I., Vidalain P.O., Jegouic S., Mirabelli C., Bessaud M., Combelas N., Autret A., Tangy F., Delpeyroux F., Blondel B. The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication. J. Virol. 2013;87:11031&#x2013;11046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807280</ArticleId><ArticleId IdType="pubmed">23926333</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar H.M., Leyssen P., Thibaut H.J., de Palma A., van der Linden L., Lanke K.H., Lacroix C., Verbeken E., Conrath K., Macleod A.M., Mitchell D.R., Palmer N.J., van de Poel H., Andrews M., Neyts J., van Kuppeveld F.J. A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIbeta. Antimicrob. Agents Chemother. 2013;57:4971&#x2013;4981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3811463</ArticleId><ArticleId IdType="pubmed">23896472</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO, 2015. Emerging Disease Surveillance and Response. &#x3008;http://www.wpro.who.int/emerging_diseases/en/&#x3009;</Citation></Reference><Reference><Citation>Wu J., Chen Z.J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 2014;32:461&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">24655297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K.X., Ng M.M., Chu J.J. Developments towards antiviral therapies against enterovirus 71. Drug Discov. Today. 2010;15:1041&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.H., Yang C.F., Guo N.N., Zhu K., Luo K.M., Zhang N., Zhao H., Cui Y., Chen L., Wang H.Y., Gu J., Ge B.X., Qin C.F., Leng Q.B. Type I interferons triggered through the toll-like receptor 3-TRIF pathway control Coxsackievirus A16 infection in young mice. J. Virol. 2015;89:10860&#x2013;10867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4621134</ArticleId><ArticleId IdType="pubmed">26292317</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee P.T., Poh C.L. Development of novel vaccines against Enterovirus-71. Viruses. 2015:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728561</ArticleId><ArticleId IdType="pubmed">26729152</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., He Y., Chen Y., Kung H.F., He M.L. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir. Ther. 2011;16:51&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip C.C., Lau S.K., Woo P.C., Yuen K.Y. Human enterovirus 71 epidemics: what's next? Emerg. Health Threat. J. 2013;6:19780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772321</ArticleId><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>